Pharmacological prophylaxis of post-traumatic epilepsy

Drugs

Volumn 59, Issue 5, 2000, Pages 1091-1099

  Iudice, Alfonso ^a   Murri, Luigi ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 PHOSPHONOMETHYLPIPECOLIC ACID; 6,7 DICHLORO 5 NITRO 2,3 QUINOXALINEDIONE; ANTICONVULSIVE AGENT; ANTIOXIDANT; APTIGANEL; CARBAMAZEPINE; DIZOCILPINE; ELIPRODIL; GAVESTINEL; LUBELUZOLE; MACROGOL; MDL 74180; MEPREDNISONE; MONTIRELIN; N (7 HYDROXY 2,2,4,6 TETRAMETHYL 1 INDANYL) 4 (3 METHOXYPHENYL) 1 PIPERAZINEACETAMIDE; N(G) METHYLARGININE; NALMEFENE; NIMODIPINE; PERGORGOTEIN; PHENOBARBITAL; PHENYTOIN; S NITROSOGLUTATHIONE; SCAVENGER; SHOSAIKOTO GO KEISHIKASHAKUYAKUTO; SIPATRIGINE; TETRODOTOXIN; TIRILAZAD; TOCOPHEROL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID;

HUMAN; NONHUMAN; PEROXIDATION; PREDICTION; REVIEW; RISK FACTOR; SEIZURE; TRAUMATIC EPILEPSY;

EID: 0034081228     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200059050-00005     Document Type: Review

References (124)

1. 1. Jensen RL, Stone JL. Benjamin Winslow Dudley and early American trephination for post-traumatic epilepsy. Neurosurgery 1997; 41: 263-8
2. 2. Walker AE, Blumer D. The fate of World War II veterans with posttraumatic seizures. Arch Neurol 1989; 46: 23-6
3. 3. Hoff H, Hoff H. Fortschritte in der Behandlung der Epilepsie. Monatsschr Psychiat Neurol 1947; 114: 105-18
4. 4. Birkmayer W. Die Behandlung der traumatischen epilepsie. Wien Klin Wochenschr 1951; 63: 606-9
5. 5. Servit Z. Prophylactic treatment of posttraumatic epilepsy. Nature 1960; 188: 669-70
6. 6. Jennett WB, Levin WS. Traumatic epilepsy after closed head injuries. J Neurol Neurosurg Psychiatry 1960; 23: 295-301
7. 7. Popek K, Musil F. Clinical trial to prevent posttraumatic epilepsy after severe brain injuries in adult [in Czechoslovakian]. Cas Lek Cesk 1969; 108: 133-47
8. 8. Adeloye A, Odeku EL. Epilepsy after missile wounds of the head. J Neurol Neurosurg Psychiatry 1971; 34: 98-103
9. 9. Jennett WB. Epilepsy after non-missile head injuries. London: Heinemann Medical Books, 1975
10. 10. Young B, Rapp RP, Brooks WH, et al. Posttraumatic epilepsy prophylaxis. Epilepsia 1979; 20: 671-81
11. 11. Murri L, Parenti G, Bonuccelli U, et al. Phenobarbital prophylaxis of posttraumatic epilepsy. Ital J Neurol Sci 1980; 1: 225-30
12. 12. Zajac J. Kowalczyk K, Fabian F, et al. Epilepsy and complication after craniocerebral traumas. Monogr Neural Sci 1980; 5: 285-9
13. 13. Servit Z, Musil F. Prophylactic treatment of posttraumatic epilepsy: results of a long-term follow-up in Czechoslovakia. Epilepsia 1981; 22: 315-20
14. 14. Pechadre M, Lauxerois M, Colnet G, et al. Prevention of late post-traumatic epilepsy by phenytoin in severe brain injuries: 2 years' follow-up. Presse Med 1991; 20: 841-5
15. 15. Penry JK, White BG, Brackett CE. A controlled prospective study of the pharmacological prophylaxis of posttraumatic epilepsy. Neurology 1979; 29: 600-1
16. 16. McQueen JK, Blackwood DHR, Harris P, et al. Low risk of late post-traumatic seizures following severe head injury: implications for clinical trials of prophylaxis. J Neurol Neurosurg Psychiatry 1983; 46: 899-904
17. 17. Young B, Rapp RP, Norton JA, et al. Failure of prophylactically administered phenytoin to prevent late posttraumatic seizures. J Neurosurg 1983; 58: 236-41
18. 18. Young B, Rapp RP, Norton JA, et al. Failure of prophylactically administered phenytoin to prevent posttraumatic seizures in children. Childs Brain 1983; 10: 185-92
19. 19. Temkin NR, Dikmen SS, Wilensky AJ, et al. A randomized double-blind study of phenytoin for the prevention of posttraumatic seizures. N Engl J Med 1990; 323: 497-502
20. 20. Paillas JE, Paillas N, Bureau M. Posttraumatic epilepsy. Introduction and clinical observations. Epilepsia 1970; 11: 5-15
21. 21. Rapport RL, Penry JK. A survey of attitudes towards the pharmacological prophylaxis of posttraumatic epilepsy. J Neurosurg 1973; 38: 159-66
22. 22. Johnson AL, Harris P, McQueen JK, et al. Phenytoin prophylaxis for posttraumatic seizures. J Neurosurg 1983; 59: 727-8
23. 23. Deutschmann CS, Haines SJ. Anticonvulsant prophylaxis in neurological surgery. Neurosurgery 1985; 17: 510-7
24. 24. Loiseau P, Marchal C. Epilepsie post-traumatique. Epilepsies 1990; 2: 199-202
25. 25. Majkowski J. Posttraumatic epilepsy. In: Dam M, Gram L, editors. Comprehensive epileptology. New York (NY): Raven Press, 1990: 281-8
26. 26. Murri L, Parenti G, Annegers JF. Pharmacological prophylaxis for posttraumatic epilepsy. Pisa: Pacini, 1991
27. 27. Temkin NR, Dikmen SS, Winn HR. Management of head injury. Posttraumatic seizures. Neurosurg Clin N Am 1991; 2: 425-35
28. 28. Willmore LJ. Post-traumatic epilepsy - mechanisms and prevention. In: Pedley TA, Meldrum BS, editors. Recent advances in epilepsy. London: Churchill Livingstone, 1992: 107-17
29. 29. Yablon SA. Posttraumatic seizures. Arch Phys Med Rehabil 1993; 74: 983-1001
30. 30. Dugan EM, Howell JM. Posttraumatic seizures. Emerg Med Clin North Am 1994; 12: 1081-7
31. 31. Janz D. Risk and drug prevention of epileptic seizures after cerebral lesions. Zentralbl Neurochir 1994; 55: 1-8
32. 32. Schierhout G, Roberts I. Prophylactic antiepileptic agents after head injury: a systematic review. J Neurol Neurosurg Psychiatry 1998; 64: 108-12
33. 33. de la Pena P, Porta-Etessam J. Post-traumatic epilepsy. Rev Neurol 1998; 26; 256-61
34. 34. Dunn LT, Foy PM. Anticonvulsant and antibiotic prophylaxis in head injury. Ann R Coll Surg Engl 1994; 76: 147-9
35. 35. Lee ST, Lui TN, Wong CW, et al. Early seizures after moderate closed head injury. Acta Neurochir (Wien) 1995; 137: 151-4
36. 36. Barry E, Bergey GK, Krumholz A, et al. Posttraumatic seizure types vary with the interval after head injury. Epilepsia 1997; 38 Suppl. 8: 49S-50S
37. 37. McCrory PR, Berkovic SF. Concussive convulsions. Incidence in sport and treatment recommendations. Sports Med 1998; 25: 131-6
38. 38. Wohlrab G, Schmitt B, Boltshauser E. Benign focal epileptiform discharges in children after severe head trauma: prognostic value and clinical course. Epilepsia 1997; 38: 275-8
39. 39. Pohlmann-Eden B, Bruchmeir J. Predictors and dynamics of posttraumatic epilepsy. Acta Neurol Scand 1997; 95: 257-62
40. 40. Lee ST, Lui TN, Wong CW, et al. Early seizures after severe closed head injury. Can J Neurol Sci 1997; 24: 40-3
41. 41. Rish BL, Caveness WF. Relation of prophylactic medication to the occurrence of early seizures following craniocerebral trauma. J Neurosurg 1973; 38: 155-8
42. 42. Wohns RNW, Wyler AR. Prophylactic phenytoin in severe head injuries. J Neurosurg 1979; 51: 507-9
43. 43. Young B, Rapp RP, Norton JA, et al. Failure of prophylactically administered phenytoin to prevent early posttraumatic seizures. J Neurosurg 1983; 58: 231-5
44. 44. Temkin NR, Haglund MM, Winn HR. Causes, prevention, and treatment of post-traumatic epilepsy. New Horiz 1995; 3: 518-22
45. 45. Haltiner AM, Newell DW, Temkin NR, et al. Side effects and mortality associated with use of phenytoin for early posttraumatic seizure prophylaxis. J Neurosurg 1999; 91: 588-92
46. 46. Glötzner FL, Haubitz I, Miltner F, et al. Seizure prevention using carbamazepine following severe brain injuries. Neurochirurgia (Stuttg) 1983; 26: 66-79
47. 47. Anderson GD, Gidal BE, Hendryx RJ, et al. Decreased plasma protein binding of valproate in patients with acute head trauma. Br J Clin Pharmacol 1994; 37: 559-62
48. 48. Griebel ML. Phenytoin protein binding in pediatric patients with acute traumatic injury. Crit Care Med 1990; 18: 385-91
49. 49. Rivey MP, Allington DR, Stone JD, et al. Alteration of carbamazepine pharmacokinetics in patients with traumatic brain injury. Brain Inj 1995; 9: 41-7
50. 50. Annegers JF, Grabow JD, Groover RV, et al. Seizures after head trauma: a population study. Neurology 1980; 30: 683-9
51. 51. Meirowsky AM. Notes on posttraumatic epilepsy in missile wounds of the brain. Mil Med 1982; 147: 632-4
52. 52. Credner L. Klinische und sociale Auswirkungen von Hirnschadigungen. Z Gesamte Neurol Psychiat 1930; 126: 721-57
53. 53. Salazar AM, Jabbari B, Vance SC, et al. Epilepsy after penetrating head injury. I. Clinical correlates: a report of the Vietnam Head Injury Study. Neurology 1985; 35: 1406-14
54. 54. Lockard JS, Congdon WC, Ducharme LL, et al. Prophylaxis with diphenylhydantoin and phenobarbital in alumina-gel monkey model. I. Twelve months of treatment: seizure, EEG, blood, and behavioral data. Epilepsia 1976; 17: 37-47
55. 55. Lockard JS, Ducharme LL, Congdon WC, et al. Prophylaxis with diphenylhydantoin and phenobarbital in alumina-gel monkey model. II. Fourth-month follow-up period: seizure, EEG, blood and behavioral data. Epilepsia 1976; 17: 49-57
56. 56. Rapport 2nd RL, Ojemann GA. Prophylactically administered phenytoin. Effects of the development of chronic cobalt-induced epilepsy in the cat. Arch Neurol 1975; 32: 539-48
57. 57. Willmore LJ, Triggs WJ. Effect of phenytoin and cortico-steroids on seizures and lipid peroxidation in experimental posttraumatic epilepsy. J Neurosurg 1984; 60: 467-72
58. 58. Payan H, Toga M, Berard-Badier M. The pathology of posttraumatic epilepsies. Epilepsia 1970; 11: 81-94
59. 59. McKinney RA, Debanne D, Gahwiler BH, et al. Lesion-induced axonal sprouting and hyperexcitability in the hippocampus in vitro: implications for the genesis of posttraumatic epilepsy. Nat Med 1997; 3: 990-6
60. 60. Bush PC, Prince DA, Miller KD. Increased pyramidal excitability and NMDA conductance can exlain posttraumatic epileptogenesis without disinhibition: a model. J Neurophysiol 1999; 82: 1748-58
61. 61. Angeleri F, Majkowski J, Cacchiò G, et al. Posttraumatic epilepsy risk factors: one-year prospective study after head injury. Epilepsia 1999; 40: 1222-30
62. 62. Asikainen I, Kaste M, Sarna S. Early and late posttraumatic seizures in traumatic brain injury rehabilitation patients: brain injury factors causing late seizures and influence of seizures on long-term outcome. Epilepsia 1999; 40: 584-9
63. 63. Schultze M, Dauch WA, Guttinger M, et al. Risk factors for posttraumatic fits and epilepsy. Zentralbl Neurochir 1999; 60: 163-7
64. 64. Caveness WF. Epilepsy, a product of trauma in our time. Epilepsia 1976; 17: 207-15
65. 65. Weiss GH, Feeney DM, Caveness WF, et al. Prognostic factors for the occurrence of posttraumatic epilepsy. Arch Neurol 1983; 40: 7-10
66. 66. Weiss GH, Salazar AM, Vance SC, et al. Predicting posttraumatic epilepsy in penetrating head injury. Arch Neurol 1986; 43: 771-3
67. 67. Gruber R, Bubl R, Fruttiger V. Anticonvulsive prophylaxis after juvenile craniocerebral injuries: a retrospective evaluation. Z Kinderchir 1985; 40: 199-202
68. 68. Wang EC, Geyer JR, Berger MS. Incidence of postoperative epilepsy in children following subfrontal craniotomy for tumor. Pediatr Neurosurg 1994; 21: 165-73
69. 69. North JB, Penhall RK, Hanieh A, et al. Phenytoin and postoperative epilepsy: a double-blind study. J Neurosurg 1983; 58: 672-7
70. 70. Kuijlen JM, Teernstra OP, Kessels AG, et al. Effectiveness of antiepileptic prophylaxis used with supratentorial craniotomies: a meta-analysis. Seizure 1996; 5: 291-8
71. 71. Caveness WF, Meirowsky AM, Rish BL, et al. The nature of posttraumatic epilepsy. J Neurosurg 1979; 50: 545-53
72. 72. Weiss GH, Salazar AM, Vance SC, et al. Predicting phenytoin in severe head injuries. J Neurosurg 1979; 51: 507-9
73. 73. Jennett WB. Posttraumatic epilepsy: phenytoin prophylaxis [letter]. J Neurosurg 1980; 52: 291
74. 74. Hauser WA. Prevention of post-traumatic epilepsy. N Engl J Med 1990; 323: 540-2
75. 75. Bauer G, Luef G, Marosi M, et al. Phenytoin for the prevention of post-traumatic seizures [letter]. N Engl J Med 1991; 324: 341
76. 76. Massagli TL. Prophylaxis and treatment of posttraumatic epilepsy with phenytoin. West J Med 1992; 157: 663-4
77. 77. Murri L, Arrigo A, Bonuccelli U, et al. Phenobarbital in the prophylaxis of late posttraumatic seizures. Ital J Neurol Sci 1992; 13: 755-60
78. 78. Manaka S. Cooperative prospective study on posttraumatic epilepsy: risk factors and the effect of prophylactic anticonvulsant. Jpn J Psychiatry Neurol 1992; 46: 311-5
79. 79. Price DJ. The efficiency of sodium valproate as the only anticonvulsant administered to neurosurgical patients. In: Parsonage MF, Caldwell ADS, editors. The place of sodium valproate in the treatment of epilepsy. London: Academic Press, 1980: 23-30
80. 80. Temkin NR, Dikmen SS, Anderson GD, et al. Valproate therapy for prevention of posttraumatic seizures: a randomized trial. J Neurosurg 1999; 91: 593-600
81. 81. Glötzner FL. Epilepsy prophylaxis with carbamazepine in severe head injuries. In: Murri L, Parenti G, Annegers JF, editors. Pharmacological prophylaxis for posttraumatic epilepsy. Pisa: Pacini, 1991: 59-72
82. 82. Shin C, Rigsbee LC, McNamara JO. Anti-seizure and anti-epileptogenic effect of gamma-vinyl gamma-aminobutyric acid in amygdaloid kindling. Brain Res 1986; 398: 370-4
83. 83. Rubin JJ, Willmore LJ. Prevention of iron-induced epileptiform discharges in rats by treatment with antiperoxidants. Exp Neurol 1980; 67: 472-80
84. 84. Kabuto H, Yokoi I, Habu H, et al. Reduction in nitric oxide synthase activity with development of an epileptogenic focus induced by ferric chloride in the rat brain. Epilepsy Res 1996; 25: 65-8
85. 85. Yokoi I, Toma J, Liu J, et al. Adenosines scavenged hydroxy radicals and prevented posttraumatic epilepsy. Free Radic Biol Med 1995; 19: 473-9
86. 86. Schubert P, Kreutzberg GW. Cerebral protection by adenosine. Acta Neurochir (Wien) 1993; 57: 80-8
87. 87. Willmore LJ, Triggs WJ, Gray JD. The role of iron-induced hippocampal peroxidation in acute epileptogenesis. Brain Res 1986; 382: 422-6
88. 88. Demopoulos HB, Flamm ES, Seligman ML, et al. Antioxidant effects of barbiturates in model membranes undergoing free radical damage. Acta Neurol Scand 1977; 7: 12-3
89. 89. Kontos HA, Wei EP. Superoxide production in experimental brain injury. J Neurosurg 1986; 64: 803-7
90. 90. Hall ED, Yonkers PA, McCall JM, et al. Effects of the 21-aminosteroid U74006F on experimental head injury in mice. J Neurosurg 1988; 68: 456-61
91. 91. Muizelaar JP, Marmarou A, Young HF, et al. Improving the outcome of severe head injury with the oxygen radical scavenger polyethylene glycol-conjugated superoxide dismutase: a phase II trial. J Neurosurg 1993; 78: 375-82
92. 92. Toulmond S, Serrano A, Benavides J, et al. Prevention by eliprodil (SL 82.0715) of traumatic brain damage in the rat. Existence of a large (18h) therapeutic window. Brain Res 1993; 620: 32-41
93. 93. Greenberg RS, Helfaer MA, Kirsh JR, et al. Nitric oxide synthase inhibition with NG-mono-methyl-L-arginine reversibly decreases cerebral blood flow in piglets. Crit Care Med 1994; 22: 384-92
94. 94. Musleh W, Bruce A, Malfroy B, et al. Effects of EUK-8, a synthetic catalytic superoxide scavenger, on hypoxia-and acidosis-induced damage in hippocampal slices. Neuropharmacology 1994; 33: 929-34
95. 95. Bullock R. Strategies for neuroprotection with glutamate antagonists. Extrapolating from evidence taken from the first stroke and head injury studies. Ann N Y Acad Sci 1995; 765: 272-8
96. 96. Smith DH, Gennarelli TA, McIntosh TK. The potential of 21 aminosteroids (lazaroids) as neuroprotective therapies in CNS injury. CNS Drugs 1995; 3: 159-63
97. 97. Tsuchida E, Bullock R. The effect of the glycine site-specific N-methyl-D-aspartate antagonist ACEA1021 on ischemic brain damage caused by acute subdural hematoma in the rat. J Neurotrauma 1995; 12: 279-88
98. 98. Komatsu M, Hiramatsu M, Yokoyama H, et al. Effect of TJ-960 (a japanese herbal medicine) on free radical changes within an iron-induced focal epileptogenic region in rat brain measured by in vivo L-band electron spin resonance. Neurosci Lett 1996; 205: 189-92
99. 99. Petty MA, Poulet P, Haas A, et al. Reduction of traumatic brain injury-induced cerebral oedema by a free radical scavenger. Eur J Pharmacol 1996; 307: 149-55
100. 100. Tsuchida E, Harms JF, Woodward JJ, et al. A use-dependent sodium channel antagonist, 619C89, in reduction of ischemic brain damage and glutamate release after acute subdural hematoma in the rat. J Neurosurg 1996; 85: 104-11
101. 101. Young B, Runge JW, Waxman KS, et al. Effects of pegorgotein on neurologic outcome of patients with severe head injury. A multicenter, randomized controlled trial. JAMA 1996; 276: 538-43
102. 102. Bordi F, Pietra C, Ziviani L, et al. The glycine antagonist GV150526 protects somatosensory evoked potentials and reduces the infarct area in the MCAo model of focal ischemia in the rat. Exp Neurol 1997; 145: 425-33
103. 103. Dewitt DS, Prough DS, Uchida T, et al. Effects of nalmefene, CG3703, tirilazad, or dopamine on cerebral blood flow, oxygen delivery, and electroencephalographic activity after traumatic brain injury and hemorrhage. J Neurotrauma 1997; 14: 931-41
104. 104. Kawamata T, Katayama Y, Maeda T, et al. Antioxidant, OPC-14117, attenuates edema formation and behavioral deficits following cortical contusion in rats. Acta Neurochir (Wien) 1997; 70 Suppl.: 191-3
105. 105. Lees KR. Cerestat and other NMDA antagonists in ischemic stroke. Neurology 1997; 49 Suppl. 4: 66S-9S
106. 106. Maiese K, TenBroeke M, Kue I. Neuroprotection of lubeluzole is mediated through the signal transduction pathways of nitric oxide. J Neurochem 1997; 68: 710-4
107. 107. Baker K, Marcus CB, Huffman K, et al. Synthetic combined superoxide dismutase/catalase mimetics are protective as a delayed treatment in a rat stroke model: a key role for reactive oxygen species in ischemic brain injury. J Pharmacol Exp Ther 1998; 284: 215-21
108. 108. Kabuto H, Yokoi I, Ogawa N. Melatonin inhibits iron-induced epileptic discharges in rats by suppressing peroxidation. Epilepsia 1998; 39: 237-43
109. 109. Kucukkaya B, Aker R, Yuksel M, et al. Low dose MK-801 protects against iron-induced oxidative changes in a rat model of focal epilepsy. Brain Res 1998; 788: 133-6
110. 110. Rauhala P, Lin AM, Chiueh CC. Neuroprotection by S-nitrosoglutathione of brain dopamine neurons from oxidative stress. FASEB J 1998; 12: 165-73
111. 111. Braakman R. The European Study Group on Nimodipine in severe head injury. A multicenter trial of the efficacy of nimodipine on outcome after head injury. J Neurosurg 1994; 80: 797-804
112. 112. Hans P, Triffaux M, Bonhomme V, et al. Control of drug-resistant epilepsy after head injury with intravenous nimodipine. Acta Anaesthesiol Belg 1994; 45: 175-8
113. 113. Cunitz G. Early management of head injury. Acta Anaesthesiol Scand 1997; 111: 46-7
114. 114. Graber KD, Prince DA. Tetrodotoxin prevents posttraumatic epileptogenesis in rats. Ann Neurol 1999; 46: 234-42
115. 115. Deymeer F, Leviton A. Posttraumatic seizures: an assessment of the epidemiologic literature. Cent Nerv Syst Trauma 1985; 2: 33-43
116. 116. Annegers JF. The incidence of epilepsy after head trauma. In: Murri L, Parenti G, Annegers JF, editors. Pharmacological prophylaxis of posttraumatic epilepsy. Pisa: Pacini, 1991: 7-16
117. 117. American Association of Neurological Surgeons. Guidelines for the management of severe head injuries. Neurol Alert 1997; 5: 35-6
118. 118. Brain Injury Special Interest Group of the American Academy of Physical Medicine and Rehabilitation. Practice parameter: antiepileptic drug treatment of posttraumatic seizures. Arch Phys Med Rehabil 1998; 79: 594-7
119. 119. Dauch WA, Schütze M, Güttinger M, et al. Post-traumatic seizure prevention-results of a survey of 127 neurosurgery clinics. Zentralbl Neurochir 1996; 57: 190-5
120. 120. Hernandez TD. Preventing post-traumatic epilepsy after brain injury: weighing the costs and benefits of anticonvulsant prophylaxis. Trends Pharmacol Sci 1997; 18: 59-62
121. 121. Hernandez TD, Naritoku DK. Seizures, epilepsy, and functional recovery after traumatic brain injury: a reappraisal. Neurology 1997; 48: 803-6
122. 122. Dikmen SS, Temkin NR, Miller B, et al. Neurobehavioral effects of phenytoin prophylaxis of posttraumatic seizures. JAMA 1991; 265: 1271-7
123. 123. Massagli TL. Neurobehavioral effects of phenytoin, carbamazepine, and valproic acid: implications for use in traumatic brain injury. Arch Phys Med Rehabil 1991; 72: 219-26
124. 124. Haltiner AM, Temkin NR, Winn HR, et al. The impact of posttraumatic seizures on 1-year neuropsychological and psychological outcome of head injury. J Int Neuropsychol Soc 1996; 2: 494-504